India Considers Opening Markets to FDA, EU-Approved Drugs

International Pharmaceutical Regulatory Monitor
A A
Indian regulators may begin letting some U.S.- and EU-approved drugs onto the Indian market without local Phase III clinical trials.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor